Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | mucolipin 3 | 0.0069 | 0.5 | 0.5 |
Schistosoma mansoni | mucolipin | 0.0069 | 0.5 | 0.5 |
Echinococcus granulosus | mucolipin 3 | 0.0069 | 0.5 | 0.5 |
Loa Loa (eye worm) | mucolipin 1 | 0.0069 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 4.1 uM | Cytotoxicity against human HL60 cells after 48 hrs | ChEMBL. | 19427790 |
CC50 (functional) | = 8.4 uM | Cytotoxicity against human HSC2 cells after 48 hrs | ChEMBL. | 19427790 |
CC50 (functional) | = 9.6 uM | Cytotoxicity against human HSC4 cells after 48 hrs | ChEMBL. | 19427790 |
CC50 (functional) | = 9.7 uM | Cytotoxicity against human HSC3 cells after 48 hrs | ChEMBL. | 19427790 |
GI (functional) | = 42 % | Growth inhibition of human CEM cells at 10 uM after 3 days relative to melphalan | ChEMBL. | 19427790 |
GI50 (functional) | -4.937 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.86 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.858 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.811 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.806 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.803 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.751 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.751 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.699 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | = 3.88 uM | Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate alamar blue assay | ChEMBL. | 20705367 |
IC50 (functional) | = 5.8 uM | Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by BacTiter-Glo cell viability assay | ChEMBL. | 27025343 |
IC50 (functional) | = 5.92 uM | Growth inhibition of human CEM cells after 3 days | ChEMBL. | 19427790 |
IC90 (functional) | = 6.12 uM | Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by microplate alamar blue assay | ChEMBL. | 20705367 |
IC90 (functional) | = 11.5 uM | Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by BacTiter-Glo cell viability assay | ChEMBL. | 27025343 |
MIC (functional) | = 12.5 uM | Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by BacTiter-Glo cell viability assay | ChEMBL. | 27025343 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 19427790 | |
Mycobacterium tuberculosis | 20705367 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.